On Essentiality and the World Health Organization's Model List of Essential Medicines
<p>Background</p><p>In 1977 the World Health Organization created its first Model List of Essential Medicines—a list designed to aid countries in determining which medicines to prioritize on their National Essential Medicines Lists. In classifying drugs as “essential,” the World He...
Guardado en:
| Autores principales: | , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Ubiquity Press
2017
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/d36c6c17c2ac42b9a831b2063ce81b63 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:d36c6c17c2ac42b9a831b2063ce81b63 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:d36c6c17c2ac42b9a831b2063ce81b632021-12-02T05:30:09ZOn Essentiality and the World Health Organization's Model List of Essential Medicines2214-999610.1016/j.aogh.2017.05.005https://doaj.org/article/d36c6c17c2ac42b9a831b2063ce81b632017-06-01T00:00:00Zhttps://annalsofglobalhealth.org/articles/185https://doaj.org/toc/2214-9996<p>Background</p><p>In 1977 the World Health Organization created its first Model List of Essential Medicines—a list designed to aid countries in determining which medicines to prioritize on their National Essential Medicines Lists. In classifying drugs as “essential,” the World Health Organization has historically stressed drugs' ability to meet priority health needs of populations and cost.</p><p>Objectives</p><p>In this paper we trace the fluctuations in the application of cost and priority status of disease as criteria for essential medicines throughout the reports published by the WHO Expert Committee on Selection and Use of Essential Medicines since 1977.</p><p>Methods</p><p>We analyzed essential medicines lists published on the World Health Organization website since 1977 for trends in criteria concerning cost and priority status of disease. Where, available, analyzed the World Health Organization Expert Committee analysis rationalizing why certain medicines were or were not added and were or were not removed.</p><p>Results</p><p>The application of the criteria of cost and priority status of essential medicines has fluctuated dramatically over the years.</p><p>Conclusions</p>The definition of essential medicines has shifted and now necessitates a new consensus on normative definitions and criteria. A more standardized and transparent set of procedures for choosing essential medicines is required.Victoria A. MarksStephen R. LathamSandeep P. KishoreUbiquity Pressarticleessential medicinesgovernanceWorld Health OrganizationInfectious and parasitic diseasesRC109-216Public aspects of medicineRA1-1270ENAnnals of Global Health, Vol 83, Iss 3-4, Pp 637-640 (2017) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
essential medicines governance World Health Organization Infectious and parasitic diseases RC109-216 Public aspects of medicine RA1-1270 |
| spellingShingle |
essential medicines governance World Health Organization Infectious and parasitic diseases RC109-216 Public aspects of medicine RA1-1270 Victoria A. Marks Stephen R. Latham Sandeep P. Kishore On Essentiality and the World Health Organization's Model List of Essential Medicines |
| description |
<p>Background</p><p>In 1977 the World Health Organization created its first Model List of Essential Medicines—a list designed to aid countries in determining which medicines to prioritize on their National Essential Medicines Lists. In classifying drugs as “essential,” the World Health Organization has historically stressed drugs' ability to meet priority health needs of populations and cost.</p><p>Objectives</p><p>In this paper we trace the fluctuations in the application of cost and priority status of disease as criteria for essential medicines throughout the reports published by the WHO Expert Committee on Selection and Use of Essential Medicines since 1977.</p><p>Methods</p><p>We analyzed essential medicines lists published on the World Health Organization website since 1977 for trends in criteria concerning cost and priority status of disease. Where, available, analyzed the World Health Organization Expert Committee analysis rationalizing why certain medicines were or were not added and were or were not removed.</p><p>Results</p><p>The application of the criteria of cost and priority status of essential medicines has fluctuated dramatically over the years.</p><p>Conclusions</p>The definition of essential medicines has shifted and now necessitates a new consensus on normative definitions and criteria. A more standardized and transparent set of procedures for choosing essential medicines is required. |
| format |
article |
| author |
Victoria A. Marks Stephen R. Latham Sandeep P. Kishore |
| author_facet |
Victoria A. Marks Stephen R. Latham Sandeep P. Kishore |
| author_sort |
Victoria A. Marks |
| title |
On Essentiality and the World Health Organization's Model List of Essential Medicines |
| title_short |
On Essentiality and the World Health Organization's Model List of Essential Medicines |
| title_full |
On Essentiality and the World Health Organization's Model List of Essential Medicines |
| title_fullStr |
On Essentiality and the World Health Organization's Model List of Essential Medicines |
| title_full_unstemmed |
On Essentiality and the World Health Organization's Model List of Essential Medicines |
| title_sort |
on essentiality and the world health organization's model list of essential medicines |
| publisher |
Ubiquity Press |
| publishDate |
2017 |
| url |
https://doaj.org/article/d36c6c17c2ac42b9a831b2063ce81b63 |
| work_keys_str_mv |
AT victoriaamarks onessentialityandtheworldhealthorganizationsmodellistofessentialmedicines AT stephenrlatham onessentialityandtheworldhealthorganizationsmodellistofessentialmedicines AT sandeeppkishore onessentialityandtheworldhealthorganizationsmodellistofessentialmedicines |
| _version_ |
1718400379955183616 |